1-[(6-fluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonyl]-3-[8-[[3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-6-yl]oxymethyl]-1,2,3,5,6,7-hexahydro-s-indacen-4-yl]urea
C39H43FN8O9S2 — CID 153260509
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[(6-fluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonyl]-3-[8-[[3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-6-yl]oxymethyl]-1,2,3,5,6,7-hexahydro-s-indacen-4-yl]urea
1-[(6-fluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonyl]-3-[8-[[3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-6-yl]oxymethyl]-1,2,3,5,6,7-hexahydro-s-indacen-4-yl]urea (PubChem CID 153260509) has the molecular formula C39H43FN8O9S2 and a molecular weight of 850.95 g/mol. Its IUPAC name is 1-[(6-fluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonyl]-3-[8-[[3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-6-yl]oxymethyl]-1,2,3,5,6,7-hexahydro-s-indacen-4-yl]urea.
Molecular Properties
| Compound Name | 1-[(6-fluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonyl]-3-[8-[[3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-6-yl]oxymethyl]-1,2,3,5,6,7-hexahydro-s-indacen-4-yl]urea |
|---|---|
| PubChem CID | 153260509 |
| Molecular Formula | C39H43FN8O9S2 |
| Molecular Weight | 850.95 g/mol |
| Exact Mass | 850.26 |
| IUPAC Name | 1-[(6-fluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonyl]-3-[8-[[3-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoylsulfamoyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-6-yl]oxymethyl]-1,2,3,5,6,7-hexahydro-s-indacen-4-yl]urea |
| SMILES | O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1cnn2c1OCC(OCc1c3c(c(NC(=O)NS(=O)(=O)c4cnn5c4OCC(F)C5)c4c1CCC4)CCC3)C2 |
| InChI | InChI=1S/C39H43FN8O9S2/c40-23-16-47-36(56-18-23)32(14-41-47)58(51,52)46-39(50)44-35-29-11-3-9-27(29)31(28-10-4-12-30(28)35)20-55-24-17-48-37(57-19-24)33(15-42-48)59(53,54)45-38(49)43-34-25-7-1-5-21(25)13-22-6-2-8-26(22)34/h13-15,23-24H,1-12,16-20H2,(H2,43,45,49)(H2,44,46,50) |
| InChIKey | WVDHPBPVHGTXKF-UHFFFAOYSA-N |
| XLogP | 3.76 |
| TPSA | 213.87 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 59 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 850.95 |
| LogP ≤ 5 | 3.76 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 13 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153260509 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.